Lotus Clinical Research, LLC

We are a CRO and Research Site focused on improving the scientific accuracy of analgesic programs. As a leading analgesic CRO, Lotus Clinical Research offers a robust CRO infrastructure, program-wide scientific support, as well as extensive analgesic and pain-related expertise in a complete turnkey solution for clients. Our specialties include Analgesics (Acute and Chronic Pain), Phase 1/Proof-of Concept, Opioid-Induced Constipation, Hospital-based Populations, Post-Operative Nausea and Vomiting, and Topical Hemostasis. Established in 2001, Lotus Clinical Research operates a 50-bed, Phase 1-3 privately owned research unit located on the 675-bed Huntington Hospital campus in Pasadena, California. Since our inception in 2001, Lotus has been inspected by the FDA on 9 occasions. All nine of these not-for-cause audits results in positive comments with no 483s issued. Our position inside of a major metropolitan hospital provides unprecedented access to all medical specialties / therapeutic areas and state of the art medical equipment. Our geographical location in greater Los Angeles County allows us to easily recruit from a large and ethnically diverse population of subjects. Nearly all hospital based research units are owned by the parent institution, which inevitably leads to an extended contracting process and a pain staking local IRB review cycle. Lotus has a unique private ownership business model which allows it to contract independently and utilize a central IRB, bypassing institutional bureaucracy for rapid study starts.